Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Canada
Deutschland
España
France
Italia
Schweiz (DE)
Suisse (FR)
United Kingdom
United States
Settings
Dynamic quotes
OFF
ON
Markets
Equities
North America
Europe
Asia
Oceania
Middle East
»
More Equities
Indexes
DOW JONES
S&P 500
NASDAQ 100
TSX COMP
NIKKEI 225
»
More Indexes
Currency / Forex
EUR / USD
GBP / USD
USD / JPY
USD / CAD
AUD / USD
»
More Currencies
Commodities
GOLD
Crude Oil (WTI)
Crude Oil (BRENT)
SILVER
PLATINUM
»
More Commodities
Trackers & ETF
Rankings and News
Advanced Search
Cryptocurrencies
BITCOIN
ETHEREUM
News
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Business Leaders
Cryptocurrencies
Cybersecurity
Economic calendar
Listed companies
Analyst reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit warnings
Appointments
Press Releases
Events
Corporate actions
Financial calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Telecommunications Services
Utilities
Analysis
All Analysis
Must Read
Daily briefing
Weekly market update
Stock Trading Strategies
Stock Picks
All stock picks
Subscribe
Portfolios
My Portfolio
Virtual portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment style
Yield stocks
Growth stocks
Undervalued Stocks
Investment themes
Water
Sin stocks
Biotechnology
At the foot of the Mont Blanc
Place your bets
Europe's family businesses
Let’s all cycle!
Fintechs
Ageing Population
Top / Flop
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
Screeners
Investment selections
Water
Sin stocks
Biotechnology
At the foot of the Mont Blanc
Place your bets
Europe's family businesses
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic chart
Financial calendar
Economic calendar
Sector research
Currency converter
ProRealTime Trading
Our Services
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
MarketScreener Homepage
>
Equities
>
Swiss Exchange
>
Novartis AG
NOVN
CH0012005267
NOVARTIS AG
(NOVN)
Add to my list
Report
Delayed Swiss Exchange -
01/25 11:30:53 am
86.13
CHF
+0.23%
07:12a
NOVARTIS AG
: Oddo reiterates its Neutral rating
MD
01/22
NOVARTIS AG
: Barclays keeps a Sell rating
MD
01/21
NOVARTIS AG
: annual earnings release
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
MarketScreener Strategies
Sector news Pharmaceuticals - Other
05:11p
Bolsonaro thanks China for fast-tracking COVID-19 vaccine supplies
RE
03:53p
AstraZeneca denies report vaccine less effective in elderly
RE
03:40p
Moderna Developing Vaccine Booster Shot Against Virus Strain First Identified..
DJ
03:22p
ASTRAZENECA
: Germany fears AstraZeneca vaccine won't get EU approval for those ..
RE
02:38p
ASTRAZENECA
: Italy sends warning letter to Pfizer over COVID vaccine delays
RE
02:23p
Bolsonaro says China fast-tracking supplies for COVID-19 vaccines made in Bra..
RE
01:27p
Merck Scraps Covid-19 Vaccine Candidates -- Update
DJ
01:20p
Saudi Arabia to get AstraZeneca shots in about a week from India
RE
12:31p
ASTRAZENECA
: EU Calls AstraZeneca Response to Vaccine Delays Unsatisfactory
DJ
12:29p
ABBVIE
: European Commission Approves Rinvoq to Treat Active Psoriatic Arthritis
DJ
11:50a
Moderna Developing Vaccine Booster Shot Against Virus Strain First Identified..
DJ
11:42a
ASTRAZENECA
: EU says AstraZeneca's explanation of decision to slow COVID-19 vac..
RE
10:29a
SUMITOMO DAINIPPON PHARMA
: Roivant Sciences founder to step down as CEO
RE
10:06a
EXCLUSIVE
: Pfizer wants India to order COVID-19 vaccine before pursuing approva..
RE
09:49a
MERCK
: Correction to Merck Scraps Covid-19 Vaccine Candidates Article
DJ
08:00a
U.S. goal to squeeze more COVID shots from Pfizer vials hampered by syringe p..
RE
07:35a
Indian shares end lower as Reliance drags, investors book profits
RE
07:23a
EU to require advance registration of COVID-19 vaccine exports
RE
07:21a
MERCK KGAA
: DZ Bank gives a Buy rating
MD
07:13a
ROCHE HOLDINGS AG
: Oddo reaffirms its Sell rating
MD
06:59a
Merck Scraps Covid-19 Vaccine Candidates
DJ
06:45a
Merck ends COVID vaccine program, cites inferior immune responses
RE
06:29a
ASTRAZENECA
: EU locks horns with AstraZeneca on vaccine deliveries amid 'supply..
RE
05:38a
Hong Kong formally approves Fosun Pharma-BioNTech vaccine
RE
05:38a
ASTRAZENECA
: Goldman Sachs maintains a Sell rating
MD
05:34a
ROCHE HOLDINGS AG
: JP Morgan remains Neutral
MD
05:01a
Indian shares end lower as Reliance drags, investors book profits
RE
04:52a
ASTRAZENECA
: EU seeks answers from AstraZeneca on cut to vaccine supplies in Mo..
RE
04:51a
Hong Kong formally approves Fosun-BioNTech vaccine
RE
04:41a
SINOVAC BIOTECH
: Thailand says COVID-19 vaccinations to start next month
RE
03:55a
Gold eases on doubts over U.S. stimulus passage
RE
03:24a
Sanofi Partners With Big Names to Create Joint Venture to Develop Digital Hea..
DJ
02:30a
ASTRAZENECA
: Calquence Meets Goals in Leukemia Trial
DJ
01:29a
ROCHE
: Eye Drug Faricimab Meets Primary Endpoint
DJ
01:03a
PRESS RELEASE
: Roche renews partnership with Sysmex to deliver haematology test..
DJ
01:00a
PRESS RELEASE
: Roche's faricimab meets primary -2-
DJ
01:00a
PRESS RELEASE
: Roche's faricimab meets primary endpoint in two global phase III..
DJ
01/24
TATA IN TALKS TO LAUNCH MODERNA COVI
: Et
RE
01/24
FROM FACTORY TO FARAWAY VILLAGE
: behind India's mammoth vaccination drive
RE
01/24
Asian shares rise as U.S. stimulus plans offset virus woes
RE
01/24
MODERNA
: U.S. CDC says 21.8 million doses of COVID-19 vaccines administered
RE
01/24
ASTRAZENECA
: Ecuador approves use of AstraZeneca vaccine for COVID-19
RE
01/24
ASTRAZENECA
: Italy to take legal action on COVID vaccine delays to get doses
RE
01/24
ASTRAZENECA
: Italy to take legal action over COVID vaccine delays to secure dos..
RE
01/24
ASTRAZENECA
: EU says it will make vaccine companies respect supply contracts - ..
RE
01/24
ASTRAZENECA
: India to give homegrown vaccine in seven more states this week
RE
01/23
UK vaccine roll-out speeds up but doctors want quicker second dose
RE
01/23
AstraZeneca's Covid-19 Vaccine Shortfall Threatens EU Plans to Boost Inoculat..
DJ
01/23
Italy PM says vaccine supply delays are serious contract violations
RE
01/23
ASTRAZENECA
: UK doctors call for shorter gap between Pfizer vaccine doses
RE
1
2
3
4
5
6
7
8
9
10
Next
Analysis
Novartis : buys neuroscience company Cadent for up to $770 million
More Must read
Stock Pick
NOVARTIS AG
Back to basics
More Recommendations
Official Publications
2020
Press Release
2020
3rd quarter results
2020
3rd quarter results
2020
3rd quarter results
2020
3rd quarter report
2020
Half-year results
More Official Publications
Upcoming event on NOVARTIS AG
01/26/21
FY 2020 Earnings Call
Company calendar
Upcoming sector events
01/26/21
JOHNSON & JOHNSON
: FY 2020 Earnings Release
01/28/21
LUPIN LIMITED
: Q3 2021 Earnings Release
01/28/21
SUMITOMO DAINIPPON PHARMA CO., LTD.
: Q3 2020 Earnings Release
01/29/21
ASTELLAS PHARMA INC.
: Q3 2020 Earnings Release
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Pharmaceuticals - NEC
Slave